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A B S T R A C T
Purpose
To assess the comprehension of common medical terms used in prostate cancer in patient
education materials to obtain informed consent, and to measure outcomes after prostate cancer
treatment. We address this issue among underserved, African-American men because of the
increased cancer incidence and mortality observed in this population.
Patients and Methods
We reviewed patient education materials and prostate-specific quality-of-life instruments to
identify technical terms describing sexual, urinary, and bowel function. Understanding of these
terms was assessed in face-to-face interviews of 105, mostly African-American men, age  40,
from two low-income clinics. Comprehension was evaluated using semiqualitative methods coded
by two independent investigators. Demographics were collected and literacy was measured.
Results
Fewer than 50% of patients understood the terms “erection” or “impotent.” Only 5% of patients
understood the term “incontinence” and 25% understood the term “bowel habits.” More patients
recognized word roots than related terms or compound words (eg, “rectum” v “rectal urgency,”
“intercourse” v “vaginal intercourse”). Comprehension of terms from all domains was statistically
significantly correlated with reading level (P  .001). Median literacy level was fourth to sixth
grade. Prostate cancer knowledge was poor. Many patients had difficulty locating key ana-
tomic structures.
Conclusion
Limited comprehension of prostate cancer terms and low literacy create barriers to obtaining
informed consent for treatment and to measuring prostate cancer outcomes accurately in our
study population. In addition, the level of prostate cancer knowledge was poor. These results
highlight the need for prostate cancer education efforts and outcomes measurements that
consider literacy and use nonmedical language.
J Clin Oncol 27:2015-2021. © 2009 by American Society of Clinical Oncology
INTRODUCTION
Prostate cancer is the most commonly diagnosed
noncutaneous cancer in men in the United States
and the second leading cause of cancer death. It is
estimated that 186,320 men were diagnosed with
prostate cancer in 2008 and 28,660 men will die of
it.1 For reasons that are unclear, prostate cancer dis-
proportionately affects African-American men, who
suffer an approximately 1.7 times increased inci-
dence and 2.4 times increased cancer mortality com-
pared with white men.2
Despite these statistics, prostate cancer screen-
ing and treatment are highly controversial.3-5 Pros-
tate cancer screening has not yet been shown to
increase overall survival or decrease cancer-specific
mortality.5,6 Moreover, any potential survival bene-
fit must be weighed against the adverse effects of
standard treatments including impotence, inconti-
nence, and bowel symptoms.7-12
Research in the past 13 years has shown that the
adverse effects of early prostate cancer treatment are
both prevalent and long-term.12-16 One large na-
tional study reported 63.5% of men treated with
external beam radiation and 79.3% treated with
radical prostatectomy were impotent 5 years after
treatment.16 Consequently, most major US and
Canadian medical organizations recommend that
clinicians should not screen patients for prostate
cancer without discussing the uncertain benefits and
possible harms of prostate cancer screening.5,6,17-20
Therefore, physician-patient communication
is central to the process of prostate cancer screening
and treatment. Medical terminology for urinary,
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bowel, and sexual function is often used to explain the tradeoffs in-
volved in prostate cancer screening, to obtain informed consent,
and in patient education materials.7-10,21-31 In addition, this termi-
nology is used to measure quality of life (QOL) and outcomes after
prostate cancer treatment.14,32-37 Because prostate cancer dispro-
portionately affects African-American men, we conducted struc-
tured interviews to evaluate comprehension of standard medical
terms used in prostate health in an underserved, predominantly
African-American population.
PATIENTS AND METHODS
Design of the Study
The study was conducted in two low-income, general medical clinics: the
University Medical Associates Clinic at University of Virginia and the Central
Virginia Community Health Center in Buckingham County, VA. Patients
were considered eligible if they were English-speaking men  age 40 years, able
to give informed consent, and were neither physicians nor registered nurses.
After permission was obtained from the patients’ physicians, eligible partici-
pants were recruited in person for the interview. Four participants were self-
referred. We completed 107 interviews between August 2000 and May 2002.
Two patients were found to be ineligible. Ten men refused to participate, for a
refusal rate of 4.2% of men eligible to be interviewed. There were 119 men
willing to participate who provided contact information, but had schedul-
ing difficulties.
The institutional review board of the University of Virginia approved the
study for use in both clinics. Written informed consent was obtained from
each patient after the interviewer read aloud the consent form and answered
any of the patient’s questions. Interviews were administered face-to-face and
read aloud. Patients were remunerated $20.00.
Data Collection and Analysis
The questionnaire was developed based on a review of patient educa-
tion materials for prostate cancer screening and treatment,23,26,38,39 and
seven prostate-specific health status questionnaires used to measure
prostate-specific QOL.14,32-37 Technical terms were identified in each instru-
ment describing sexual, urinary, and bowel function. Comprehension of these
twenty-eight terms was assessed with a series of questions that generally took
the form: 1) Is ____ a word that you know? If the respondent replied “yes”, two
further questions were asked: 2) What are the other words that you’ve heard
for ____? 3) What happens when a man has ____? The content and structure
of these questions were developed with a medical anthropologist (G.F.) based
on ethnographic field methods.40 Prostate cancer knowledge was assessed
using questions previously validated in a large survey of Canadian men.41 To
assess comprehension of key anatomic structures, patients were shown two
male anatomic drawings using anterior and midsagittal views and asked their
location and function. Reading level was assessed using the Rapid Estimate of
Adult Literacy in Medicine.42 Patients were asked to cross out two thirds of
nine, 30% of 10, and 30% of 100 using stick figures to assess numeracy.
Participants were asked to self-describe race, provide age, address, household
income, highest grade level completed in school, insurance type, and describe
their living arrangement at home. Before the study, the interview was tested for
acceptability, content, wording, and burden on respondents and was found to
be satisfactory.
Two trained interviewers, one female and one male, and the principal
investigator (a female) conducted the interviews. Patient responses were cap-
tured in detailed written forms. All interviews were audiotaped and a random
sample of 10% of all audiotapes were reviewed and compared with the written
data for quality control. Two independent trained coders determined compre-
hension of prostate-specific terms according to specified criteria. Those pa-
tients who responded “no” to the question, “Is ____ a word that you know?”
were scored as not understanding the term. The two coders independently,
and blinded to each other’s initial assessment, determined whether partici-
pants who responded “yes” to the question correctly understood or misinter-
preted the term, based on the participant’s responses to subsequent and related
questions. Scores were then unblinded and scoring disagreements were re-
viewed by the two coders in an effort to reach consensus. Continued
disagreements were reviewed by a tie-breaking third independent coder.
Initial inter-rater agreement was 91.9%; failure to reach consensus was 0.23%.
Statistical Analysis
Analyses were conducted with the SAS statistical software package
(SAS Institute, Cary, NC). Questions that were skipped by patients were
excluded from analyses. Standard methods based on the binomial distri-
bution were used to calculate CIs. Pearson correlation coefficients were
used to estimate the association between literacy and the proportion of
correctly identified terms in each domain (sexual function, urinary func-
tion, and bowel function). CIs and tests for the correlation coefficients
were computed using the Fisher z-transformation.43
Qualitative Analysis
The inductive framework of grounded theory was used with content
analysis to examine recurring themes in the misunderstanding of prostate
cancer.44-48 Detailed written interview notes were reviewed by three authors
(E.M.N., K.L.K., G.F.) and used to develop initial coding categories. Two
authors (E.M.N., K.L.K.) then independently coded each interview using both
notes and audiotaped data to refine themes and aggregate the data into quali-
tative domains and subcategories within those domains. Coding between the
two authors was compared every four to five interviews and disagreements
Table 1. Patient Demographics and Study Characteristics (N  105)
Characteristic No. %
Average age, years 58
Self-described race
African American 91 87
White 14 13
Rural residence 74 70
Income
Median household 16,000






Do not know 3 3
Highest education
 6th grade 27 26
Middle school 11 10
Some high school 30 29
High school graduate 23 22
Some college 14 13
Literacy
Illiterate 9 9
 3rd grade 19 18
4th-6th grade 18 17
7th-8th grade 26 25
High school 24 23
Skip or no glasses 9 9
Numeracy
Calculated fraction correctly 41 39
Calculated percent correctly 32 30
Both fraction and percent calculated correctly 21 20
Prostate cancer or TURP survivor† 12 11
Abbreviation: TURP, transurethral resection of the prostate.
Patient must calculate both 30% of 10 and 30% of 100 correctly.
†Thirty-three percent illiterate or  3rd grade reading level, 8% can calculate
both fraction and percent correctly.
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reconciled to consensus based on data. The coding framework was updated
iteratively. Representative quotations were transcribed from audiotapes.
RESULTS
Patients
Patient demographics and study characteristics are summarized
in Table 1. Patients were on average 58 years old (range, 40 to 89).
Most patients (75%) self-described their race as African American or
black, but a few men (11%) described their race as negro or colored.
Thirteen percent of patients described themselves as white. Most pa-
tients lived in a rural residence according to year 2000 census criteria.49
Median annual household income was $16,000. Just more than half
the patients were uninsured or had Medicaid. Most patients (65%)
had not completed high school and 26% did not receive more than a
grammar school education. Only three patients had completed four
years of college. Fewer than half the patients read above the sixth grade
level and 27% were illiterate or read at third grade level or lower.
Twenty percent of the men were able to calculate both a fraction and a
percent. There were nine men who reported that they were prostate
cancer survivors and three men who reported that they had under-
gone transurethral resection of the prostate (TURP).
Prostate Cancer Terms
The understanding of prostate cancer terms among the men in
our study population is described in Figure 1. In the domain of sexual
function, the words “impotent” and “erection” were correctly under-
stood by fewer than 50% of the men. Although “intercourse” was one
of the best understood words in the interview, 68% of the men said
they did not know the related compound term, “vaginal intercourse.”
There were 65 patients (62%) who knew the word “rectum,” but only
23% said they knew the term “rectal urgency.” In the domain of
urinary function, “urine” and “urination” were understood by 70%
and 79% of men, respectively. Fewer than 50% of patients, however,
correctly understood the derivative terms “urinary frequency” and
“urinary function.” “Incontinence” was the least understood term in
the interview; 95% of patients did not know the word or misinter-
preted it. We found that understanding of terms in all three domains
was correlated with literacy as measured by the Rapid Estimate of
Adult Literacy in Medicine raw score (0 to 66, P  .001; Table 2).
Anatomic Identification and Function
The ability to identify key anatomic structures and name their
functions is presented in Table 3. The majority of men could not locate
the prostate, 29% could not locate the bowels, and 35% could not
locate the bladder. Most men could locate the penis. A few men who
did not recognize the standard medical term when asked to “point to
the penis” could still provide a correct colloquial name when asked
“What do you call this?”
Misunderstanding of the Prostate and
Prostate Cancer
There were 91 men (87%) who had heard of the prostate, but
only 62 (59%) could name something that goes wrong with it and just
two men could describe the function of the prostate. Quantitative
analysis demonstrated that overall prostate cancer knowledge was
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Fig 1. Comprehension of selected terms
in the sexual, bowel, and urinary function
domains by proportion of total study popu-
lation (estimated with an SE that is no  5
percentage points). Blue bars represent
the proportion that correctly understood
the term. Gold bars and gray bars repre-
sent the proportions that did not know
the term and that misinterpreted the
term, respectively.
Table 2. Correlation Coefficients Between Literacy and the Proportion of





Literacy 0.79 0.66 0.62
95% CI 0.70 to 0.85 0.53 to 0.76 0.48 to 0.73
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Only three men of 105 were able to name race as a risk factor. Further
insight into patterns of misunderstanding was gained with qualitative
analysis in which two broad themes emerged. The first major theme
was “inability to distinguish the normal prostate from prostate can-
cer.” When asked “what does the prostate do?” one participant ex-
plained, “I guess it eats you up, I guess it’s cancer.” Another patient, a
prostate cancer survivor, replied, “it takes your nature [a colloquial
term for sexual function] from you is one of the things it does. You
Table 3. Anatomic Identification and Function
Item
Correct Identification






(N  105) 95% C % 95% CI % 95% CI % 95% CI % 95% CI
All Men
(N  105) 95% CI
Please point to the
Bladder 65 55 to 74 90 83 to 95
Bowels 71 62 to 80 75 66 to 83
Prostate 22 14 to 31 4 1 to 9
Penis 84 75 to 90 89 81 to 94
Where would you feel rectal
discomfort?
46 36 to 56
What do you call this?
Rectum 21 14 to 30 34 25 to 44 53 43 to 63
Penis 78 69 to 86 11 6 to 19 91 84 to 96
Not including 12% who pointed to the rectum.
Table 4. Prostate Cancer Knowledge
Item
Correct Agree
All Men (N  105)
Cancer and TURP
(n  12) All Men (N  105)
Cancer and TURP
(n  12)
% 95% CI % 95% CI % 95% CI % 95% CI
Chances of a man (African American) getting
prostate cancer in his lifetime (1 in 5)
17 10 to 26 17 0 to 38
Risk factors for prostate cancer
Increasing age 5 2 to 11 0 0 to 27
Family history 2 0 to 7 0 0 to 27
Race 3 1 to 8 8 0 to 38
Do not know 42 32 to 52 42 15 to 72
Misinterpret 51 41 to 61 50 21 to 79
Treatments for prostate cancer
Surgery 22 14 to 31 67 35 to 90
Radiation 13 7 to 21 25 9 to 57
Brachytherapy 2 0 to 7 8 0 to 38
Hormones 4 1 to 9 25 9 to 57
Chemotherapy 14 8 to 22 33 10 to 65
Adverse effects of prostate cancer treatment
Sexual dysfunction 7 3 to 13 25 9 to 57
Urinary dysfunction 5 2 to 11 17 0 to 38
Bowel symptoms 3 1 to 8 0 0 to 27
Hormone or chemotherapy adverse effects 16 9 to 23 17 0 to 38
Most prostate cancer can be cured if it’s
caught early enough
93 87 to 97 92 62 to 100
Most men who get prostate cancer will die of
prostate cancer
38 29 to 48 50 21 to 79
A man can have prostate cancer without pain
or symptoms
48 38 to 58 42 15 to 72
Most prostate cancer tumors are fast growing 55 45 to 65 50 21 to 79
Compared to heart disease, do you know
more, about the same, or less about
prostate cancer? (knew less, %)
55 45 to 65 50 21 to 79
Abbreviation: TURP, transurethral resection of the prostate.
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have terrible pains from it too.” These data, combined with observa-
tions of the participants during the anatomic identification section of
the interview, in which patients traced the rectum to locate the pros-
tate, indicated that many patients understand the prostate only in
the context of the physical exam used to screen for prostate cancer.
Because knowledge of the prostate was acquired directly through the
experience of digital rectal exam, 25% of interviewees thought the
prostate was synonymous with prostate cancer, 17% thought that
the prostate was located in the rectum, and 4% confused prostate
cancer with colorectal cancer.
The second major theme to emerge in content analysis was “con-
fusion of the urinary, bowel, and sexual function domains” used to
discuss prostate cancer and measure QOL among survivors. Although
assessment of these domains is an important objective of prostate
cancer outcomes measurement,14,32-37 widespread domain confusion
was evident among many patients. The misunderstandings illustrated
in the following exchanges were prevalent and severe, raising the
concern that lack of anatomic knowledge and unfamiliar medical
terms render educational and informed consent materials, and cur-
rent QOL instruments unreliable in our study population. Overall,
47% of patients confused bowel with urinary function, 32% confused
urinary with sexual function, and 27% confused bowel with sex-
ual function.
Question: What are the other words you’ve heard for uri-
nary function?
Answer: Bowel movement.
Question: What does the rectum do?
Answer: …pee, urinatin’ and all that stuff.
Question: What are the other words you’ve heard for
bowel habits?
Answer: watchacall folks that, men using men, men going with
men that’s what I’m gettin’ at.
Question: What happens when a man is incontinent?
Answer: …He’s not able to satisfy his woman or to participate in
satisfying his own self.
DISCUSSION
Historically, health literacy studies have placed an emphasis on read-
ing skills and their relationship to clinical health outcomes.50-54 More
recent studies have begun to consider mathematical skills and docu-
ment complexity.55-62 The field of health literacy has long been aware
that the language of medicine is distinct from spoken English used to
communicate in life outside the hospital.63-66 Our study is not new in
this regard. It is novel, however, for applying the ethnographic meth-
odologies of cultural anthropology to examine in detail the assump-
tions about patient language, skills, and knowledge intrinsic to current
QOL measures, cancer education, and informed consent interactions
for prostate cancer.39 We were able to explore these assumptions
among patients recruited from two low-income community clinics
serving large populations of African-American men by acknowledg-
ing that doctors often use words that do not mean much to everyday
people, reassuring participants that there are no right or wrong an-
swers, and avoiding closed ended questions.
Our investigation revealed that widespread assumptions made in
medical settings about the language for genitourinary function, read-
ing skills, math skills, prostate cancer knowledge, and anatomic
knowledge were inaccurate among patients in our study population.
The greatest limitation of our research, however, is that we cannot say
how generalizable our findings will be outside our small sample size
from two clinics in a single geographic region. Nevertheless, our re-
sults are cause for concern. We found that the median reading level
among men that we interviewed was fourth to sixth grade with 27%
reading at third-grade level or lower. Only 20% could calculate a
simple percent and fraction. We established that standard medical
language for genitourinary function was not understood well. These
terms are found in many patient education materials 18,21,25-30,67 and
QOL questionnaires,14,32-37 and are likely to be used by physicians in
discussions of prostate cancer screening and treatment.22-24,32 We
assessed prostate cancer knowledge as well as anatomic function and
location. Analysis showed that prostate cancer knowledge was poor
even among patients who had undergone treatment for prostate can-
cer or TURP. Many patients had difficulty identifying key anatomic
structures and their function. Most importantly, we found that many
commonly used medical terms were completely unknown to a large
proportion of patients and that comprehension was significantly cor-
related with health literacy. Much like a foreign language, our results
showed that patients may understand a particular term relatively well,
but may not recognize compound terms or related terms derived from
the same word root (eg, intercourse v vaginal intercourse or rectum v
rectal urgency, respectively). Similar results have been observed with
difficulty understanding vaginal intercourse and anal intercourse in
the National AIDS Behavioral Survey II.68
Because these assumptions about knowledge, skills, and language
are made in consent documents,23,31 QOL measures,14,32-37 and pa-
tient education materials,18,21,25-30,67 it is doubtful their content is
accessible to our study population. For instance, the Centers for Dis-
ease Control, the National Cancer Institute pamphlets,25,27 and the
American Cancer Society (ACS) Web site67 all explain the adverse
effects of early prostate cancer treatment in terms of impotence and
incontinence, understood by fewer than 50% and 5% of study pa-
tients, respectively. When definitions are provided for these words,
they are often couched in more medical terminology. Impotent is
defined as “unable to have a spontaneous erection” on the ACS Web
site,67 or discussed as “problems having or keeping an erection” in
plain language materials,28,29 but neither impotent nor erection was
understood by more than 50% of the patients we interviewed. Thus,
even if these materials were read aloud to overcome literacy barriers,
they may still be misunderstood by many men in our study. The math
skills expected of the reader are also an issue. Both the ACS Web site67
and the Centers for Disease Control pamphlet25 use percentages, a
calculation that only 30% of study patients could perform.
How can we apply our research findings to improve prostate
cancer communication among underserved men? We can identify
more accessible language for genitourinary function. Using the semi-
qualitative data culled from our research interviews, we have con-
structed a table of synonymous colloquial terms for the common
medical words used for prostate cancer (Appendix Table A1, online
only). We hope these findings will be useful to other investigators and
caregivers as we apply these results in the next steps of our research
plan. After confirming the social acceptability of alternative colloquial
language, we have employed a process comparable to translation, and
back translation of English to a foreign language, to adapt Patient-
Oriented Prostate Utility Scale (PORPUS), a prostate-specific QOL
Comprehension of Common Prostate Cancer Terms
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measure.33,69 Current instruments are self-administered, require rel-
atively high level reading skills, and use standard medical terms.14,32-37
Our adapted QOL instrument is a computerized, partially tailored
script that is read aloud by an interviewer. The script begins by asking
the patient to choose the words for urinary, bowel, and sexual
function that he understands most easily. The interviewer selects
these terms in the computer program, which automatically substi-
tutes the chosen colloquial terms for the standard medical language
validated in the original QOL measure. The program creates a
partially tailored QOL instrument that can be read aloud by the
interviewer. We will begin to test the adapted QOL measure among
low-income prostate cancer survivors of all races shortly, with partic-
ular concern for underserved African-American men.
In addition, we urge caregivers not to assume that patients
have a working knowledge of their internal anatomy and organ
systems. A safer place to start teaching prostate cancer is based on
what a patient sees in the mirror. We can explain anatomy step-
wise, by teaching new structures in relation to external landmarks
that every patient will know regardless of education. Similarly, we
can explain function based on what a patient directly knows of his
body from using the bathroom and having sexual relations. After
identifying colloquial language that is more meaningful to the
patient, it is important to begin teaching by anchoring our expla-
nations in the common experiences of daily living—activities that
every patient performs no matter how far they went in school.
Lastly, we can use the qualitative analysis of misunderstandings of
prostate cancer to inform subsequent explanations of prostate
cancer screening in similar patient populations. Based on study
data, we added a list of suggestions for caregivers to help clarify
the digital rectal exam during prostate cancer screening using
everyday language in an effort to prevent further misconcep-
tions (Appendix).
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